Publications by authors named "Obdulia Rabal"

Claim this Profile
E
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A toolkit for covalent docking with GOLD: from automated ligand preparation with KNIME to bound protein-ligand complexes.
Laurianne David, Anissa Mdahoma, Natesh Singh, Sébastien Buchoux, Emilie Pihan, Obdulia Rabal

Bioinform Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine tuning for success in structure-based virtual screening.
Emilie Pihan, Martin Kotev, Obdulia Rabal, Claudia Beato, Constantino Diaz Gonzalez

J Comput Aided Mol Des· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
Christophe Muller, Obdulia Rabal, Constantino Diaz Gonzalez

Methods Mol Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with Efficacy in Multiple Myeloma.
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Irene de Miguel

J Med Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.
Edgar López-López, Obdulia Rabal, Julen Oyarzabal, José L Medina-Franco

J Comput Aided Mol Des· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.
Carmen Vicente, Elena Arriazu, Elena Martínez-Balsalobre, Irene Peris, Nerea Marcotegui, Obdulia Rabal

Cancer Lett· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González

ACS Chem Neurosci· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes.
Manuel Navarro-Oviedo, Carmen Roncal, Agustina Salicio, Miriam Belzunce, Obdulia Rabal

Transl Stroke Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
Cristina Segovia, Edurne San José-Enériz, Ester Munera-Maravilla, Mónica Martínez-Fernández, Leire Garate, Obdulia Rabal

Nat Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease.
Mar Cuadrado-Tejedor, Marta Pérez-González, Cristina García-Muñoz, Damián Muruzabal, Carolina García-Barroso, Obdulia Rabal

Front Aging Neurosci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.
Sonia Martínez-González, Sonsoles Rodríguez-Arístegui, Cristina Ana Gómez de la Oliva, Ana Isabel Hernández, Esther González Cantalapiedra, Obdulia Rabal

Eur J Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González

ACS Chem Neurosci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice.
Aritz Lasarte-Cia, Teresa Lozano, Marta Pérez-González, Marta Gorraiz, Kristina Iribarren, Obdulia Rabal

Front Immunol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.
Marina Bárcena-Varela, Stefano Caruso, Susana Llerena, Gloria Álvarez-Sola, Iker Uriarte, Obdulia Rabal

Hepatology· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces.
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, Xabier Agirre, Irene de Miguel

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Amaia Vilas-Zornoza

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen.
Javier Vázquez, Alessandro Deplano, Albert Herrero, Tiziana Ginex, Enric Gibert, Obdulia Rabal

J Chem Inf Model· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization.
Obdulia Rabal, Andrea Castellar, Julen Oyarzabal

J Cheminform· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.
Jon Celay, Teresa Lozano, Axel R Concepcion, Elena Beltrán, Francesc Rudilla, Obdulia Rabal

Haematologica· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Screening To Discover Novel Chemical Series as Efficient Antihemorrhagic Agents.
Irene de Miguel, Josune Orbe, Juan A Sánchez-Arias, José A Rodríguez, Agustina Salicio, Obdulia Rabal

ACS Med Chem Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome.
Juan Roberto Rodriguez-Madoz, Edurne San Jose-Eneriz, Obdulia Rabal, Natalia Zapata-Linares, Estibaliz Miranda

PLoS One· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA).
Mario Martínez Soldevilla, Sandra Hervas, Helena Villanueva, Teresa Lozano, Obdulia Rabal

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor.
Teresa Lozano, Marta Gorraiz, Aritz Lasarte-Cía, Marta Ruiz, Obdulia Rabal

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis